We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Measurement of Cancer-Related Risk Perception in Smokers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00588211
Recruitment Status : Active, not recruiting
First Posted : January 8, 2008
Last Update Posted : October 4, 2017
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Center and Adelphi University are working together to design a new measure. Findings from this study will help us find new ways to help people avoid cancer.

Condition or disease Intervention/treatment
Cancer Related-Risks Risk Perception Survey Focus Group Behavioral: Interviews Behavioral: focus group Behavioral: Survey

Detailed Description:
The goal of the study is to develop and provide initial evidence for the reliability and validity of a measure of cancer-related risk perception. As such, the primary outcomes of the study will be initial construct validity (convergent validity and discriminant validity) of the proposed scale as evidenced by correlations of this test with other tests that vary in the degree of association to the proposed construct of cancer-related risk perception. It is anticipated that the cancer-related risk perception scale will correlate most highly (.50-.60) with measures of tobacco and environmental risk exposures, readiness to quit smoking, and family cancer history.

Study Design

Study Type : Observational
Actual Enrollment : 1514 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Measurement of Cancer-Related Risk Perception in Smokers
Study Start Date : September 2001
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2018
Groups and Cohorts

Group/Cohort Intervention/treatment
We will recruit fifteen New York University College of Dentistry (NYUCD) clinic patients who report current tobacco use.
Behavioral: Interviews
45-minute individual interviews after the conclusion of their dental appointment
Second, we will recruit thirty dental clinic smokers (10 per day for 3 days) from the NYUCD waiting room.
Behavioral: focus group
A focus group of the preliminary cancer-related risk perception item pool.
Third, we will survey 200 student participants from Adelphi University.
Behavioral: Survey
Quantitative item analysis of the final item pool.
Queens Hospital Center with 800 patients.
Behavioral: Survey
A second confirmatory factor analysis.

Outcome Measures

Primary Outcome Measures :
  1. Develop a comprehensive "blueprint," or description of the cancer-related risk perception construct; to use it to generate a cancer-related risk perception item pool; conduct an analysis of the generated items [ Time Frame: 3 years ]

Secondary Outcome Measures :
  1. to establish initial evidence for scale reliability and validity [ Time Frame: 3 years ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
  • clinic patients Queens Hospital Center
  • students participants from Adelphi University

Inclusion Criteria:

  • Subject must be >= to 18 years of age
  • For recruitment at Adelphi University: Speak English
  • For recruitment at Queens Hospital Center: Speak English
  • For recruitment at Queens Hospital Center: Must be a Queens Hospital Center Patient

Exclusion Criteria:

  • Patients who have a history of colorectal cancer at the Queens Hospital Center
  • Patients who cannot give informed consent
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00588211

United States, New York
Queens Hospital Center
Jamaica, New York, United States, 11432
New York University, College of Dentistry
New York, New York, United States, 10010
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065
Adelphi University
New York, New York, United States, 11013
Sponsors and Collaborators
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Adelphi University
Queen's Hospital Center
Principal Investigator: Jennifer L Hay, PhD Memorial Sloan Kettering Cancer Center
More Information

Additional Information:
Responsible Party: Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT00588211     History of Changes
Other Study ID Numbers: 01-121
First Posted: January 8, 2008    Key Record Dates
Last Update Posted: October 4, 2017
Last Verified: October 2017

Keywords provided by Memorial Sloan Kettering Cancer Center:
Cancer related-Risks
Risk Perception
Focus Group
Smoking cessation